OmarRKayalehMD

Gastrointestinal Cancer, Hematologic Oncology

Physician

Overview of Dr. Kayaleh

Dr. Omar Kayaleh is an oncologist in Orlando, FL and is affiliated with multiple hospitals in the area, including Orlando Health Orlando Regional Medical Center and Select Specialty Hospital-Orlando North. He received his medical degree from University of Florida College of Medicine and has been in practice 32 years. Dr. Kayaleh accepts several types of health insurance, listed below. He is one of 74 doctors at Orlando Health Orlando Regional Medical Center and one of 10 doctors at Select Specialty Hospital-Orlando North who specialize in Oncology. He has 7 publications and over 250 citings.

Office
1400 South Orange Ave.
Orlando, FL 32806
Book by Phone+1(321) 342-2492

Education & Training

Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 1993 - 1996
MedStar Franklin Square Medical CenterResidency, Internal Medicine, 1985 - 1988
University of Florida College of MedicineClass of 1985

Certifications & Licensure

FL State Medical License 1988 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Start of enrollment: 2011 Jan 01
Terminated
Phase 3
Safety and Efficacy Study of DCVax-Direct in Solid Tumors Start of enrollment: 2013 Jun 01
Unknown status
Phase 1, Phase 2
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer Start of enrollment: 2022 Feb 12
Active, not recruiting
Phase 2, Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophage...
Lisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, David Ilson, André Konski
Quality of Life Research. 2024-10-01
1 citations
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin
Future Oncology. 2023-09-01
3 citations
Hypercalcemia Resulting from Necrotizing Leiomyoma in a Pregnant Female.
Jacqueline Kropf, Mai Vo, Sarah Cheyney, Omar R. Kayaleh, Jeannie McWhorter
The American Journal of Case Reports. 2020-08-05

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Aetna Whole Health Banner Health Network
AvMed Health Open Access
BCBS Arizona BlueAlliance Network
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Health Net Arizona HMO
Health Net Arizona HMO ExcelCare Network
Health Net Arizona PPO/POS
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment